Replies to post #242381 on Biotech Values

[spartex]

TLD results just presented on the NWBO trial (link to slides within).

https://virtualtrials.org/dcvax.cfm

[jondoeuk]

PFS (original primary endpoint): 7.6 months for placebo; 6.2 months for DCVax-L.

OS (original secondary endpoint): So bad they wouldn't tell us.

But if you completely ignore that, along with other things, and cherry-pick a historical control group to use instead, then there is an under 3 month ''benefit"!